Trade Summary

1 week ago, Norwalk Leslie V, serving as Dir at NEUROCRINE BIOSCIENCES INC (NBIX), sold 1,250 shares at $182.01 per share, for a total transaction value of $227,507.50. Following this transaction, Norwalk Leslie V now holds 1,588 shares of NBIX.

This sale represents a 44.05% decrease in Norwalk Leslie V's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, July 28, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 30, 2026 at 5:29 PM ET, 2 days after the trade was made.

NEUROCRINE BIOSCIENCES INC operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.